デフォルト表紙
市場調査レポート
商品コード
1376087

ヘルスケアにおける生成AIの市場規模、シェア、動向分析レポート:コンポーネント別、機能別、最終用途別、用途別、地域別、セグメント予測、2023~2030年

Generative AI In Healthcare Market Size, Share & Trends Analysis Report By Component (Software, Service), By Function (Virtual Nursing Assistants, Robot-Assisted AI Surgery), By End-use, By Application, By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.55円
ヘルスケアにおける生成AIの市場規模、シェア、動向分析レポート:コンポーネント別、機能別、最終用途別、用途別、地域別、セグメント予測、2023~2030年
出版日: 2023年10月11日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療における生成AI市場の成長と動向:

Grand View Research, Incの最新レポートによると、医療における生成AIの世界市場規模は2030年までに147億7,000万米ドルに達する見込みです。

同市場は、2023年から2030年にかけてCAGR36.7%で成長すると予測されています。医療における生成モデルは、高解像度の医療画像を生成することで診断精度を高めています。これらのAIを搭載したモデルは、複雑な画像を生成することに優れており、がん、病変、異常などの重大な疾患の検出と診断に役立っています。強化された画質により、医療専門家は微妙な異常をより効果的に特定することができます。さらに、生成・モデルの効率とスピードは診断プロセスを迅速化し、迅速な介入と患者の転帰の改善を可能にします。

生成AIは創薬に活用され、新規化合物の創出や既存化合物の最適化を行い、医薬品開発のタイムラインを加速します。さらに、薬剤の特性や潜在的な副作用の予測を支援し、製薬業界における情報に基づいた意思決定のための貴重な洞察を提供します。例えば、スタンフォード大学の研究者によって作られたオープンソースのプラットフォームであるDeepChemは、創薬のための計算化学の進歩を推進するために、生成モデルと機械学習を採用しています。DeepChemは、分子化合物を最適化・分析するためのさまざまなツールやモデルを提供し、医療や製薬業界における多様な用途に対応しています。

生成AIは医療に変革をもたらし、個別化医療への大きな転換を可能にします。個人の遺伝子データや健康履歴を活用することで、生成AIアルゴリズムはオーダーメイドの治療計画や薬剤を作成することができます。この革新的なアプローチにより、医療介入がその人固有の遺伝的体質や健康状況に正確に沿うようになり、治療効果を最大化し、副作用を最小限に抑えることができます。医療介入をカスタマイズする生成AIの可能性は、医療における極めて重要な進歩を示し、治療が最適化され、すべての人にパーソナライズされ、最終的に全体的な医療成果を向上させる未来を約束します。

北米のヘルスケアにおける生成AI市場の足場は著しく強化され、顕著な成長の急上昇を見せています。人工知能と機械学習、特に生成・モデルの進歩が、医療における応用を後押ししています。正確な診断のための医療画像の生成から、創薬プロセスの支援、個人の遺伝子プロファイルに基づく治療計画の個別化まで、生成AIの可能性が積極的に模索され、採用されています。研究機関、医療機関、技術企業間の協力、多額のベンチャーキャピタルからの資金調達、支援的な規制の枠組みが、さまざまな医療領域への生成AIの統合をさらに後押ししています。個別化医療への需要とイノベーションへの推進力が、北米全域の医療分野における生成AIの著しい成長に寄与している主な要因です。

医療における生成AI市場レポートのハイライト

  • 機能別では、医療画像解析分野が2022年の売上高シェア28.9%で圧倒的。Generative Adversarial Networks(GANs)やVariational Autoencoders(VAEs)などの生成モデルは、忠実度の高い医療画像の生成に大きな可能性を示しています。
  • 最終用途別では、臨床研究分野が2022年の売上高シェア29.3%で市場を独占しました。生成AIは、創薬、臨床試験デザインの最適化、予測分析、調査方法の最適化など、臨床研究のさまざまな側面の支援と迅速化において大きな可能性を示しています。
  • 製薬業界は、創薬と薬剤開発のために生成AIを採用し続けています。AI主導の生成・モデルは、潜在的な新薬候補の特定と既存の新薬候補の最適化のプロセスを加速し、新薬の上市にかかる時間とコストを削減しました。
  • 生成AIは、リアルなバーチャル・シミュレーションによって医療トレーニングに革命をもたらしています。本物そっくりの患者アバターやインタラクティブな手術シナリオの作成を支援し、リスクのない環境で医療専門家のスキルを向上させる。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ヘルスケアにおける生成AI市場の変数、動向、および範囲

  • 市場系統の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 業界の課題
  • 医療市場分析ツールにおける生成AI
    • 業界分析-ポーターのファイブフォース分析
    • PESTEL分析
  • ユースケース分析

第4章 医療市場における生成AI:コンポーネント推定・動向分析

  • セグメントダッシュボード
  • ヘルスケアにおける生成AI市場:コンポーネント変動分析、100万米ドル、2022年と2030年
  • ソリューション
  • サービス

第5章 医療市場における生成AI:機能推定・動向分析

  • セグメントダッシュボード
  • ヘルスケアにおける生成AI市場:機能変動分析、100万米ドル、2022年と2030年
  • バーチャル看護助手
  • ロボット支援AI手術
  • 管理プロセスの最適化
  • 医用画像解析

第6章 医療市場における生成AI:最終用途推定・動向分析

  • セグメントダッシュボード
  • ヘルスケアにおける生成AI市場:最終用途の変動分析、100万米ドル、2022年と2030年
  • 臨床調査
  • 医療センター
  • 診断センター
  • その他

第7章 ヘルスケアにおける生成AI市場:用途推定・動向分析

  • セグメントダッシュボード
  • ヘルスケアにおける生成AI市場:用途の変動分析、100万米ドル、2022年と2030年
  • 臨床
  • システム

第8章 ヘルスケアにおける生成AI市場:地域推定・動向分析

  • ヘルスケアにおける生成AI市場シェア、地域別、100万米ドル、2022年と2030年
  • 北米
    • 北米のヘルスケアにおける生成AI市場推計・予測、2017~2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州のヘルスケアにおける生成AI市場推計・予測、2017~2030年
    • 英国
    • ドイツ
    • フランス
  • アジア太平洋
    • アジア太平洋のヘルスケアにおける生成AI市場推計・予測、2017~2030年
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ラテンアメリカのヘルスケアにおける生成AI市場推計・予測、2017~2030年
    • ブラジル
    • メキシコ
  • 中東およびアフリカ
    • 中東およびアフリカのヘルスケアにおける生成AI市場推計・予測、2017~2030年
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第9章 競合情勢

  • 企業の分類
  • 企業の市場での位置づけ
  • 参入企業概要
  • 企業ヒートマップ分析
  • 戦略マッピング
  • 企業プロファイル・一覧表
    • Google LLC
    • IBM Watson
    • Johnson &Johnson
    • Microsoft Corporation
    • Neuralink Corporation
    • NioyaTech
    • OpenAI
    • Oracle
    • Saxon
    • Syntegra
    • Tencent Holdings Ltd
図表

List of Tables

  • Table 1 Global Generative AI in Healthcare market by Component, 2017 - 2030 (USD Million)
  • Table 2 Global Generative AI in Healthcare market by Function, 2017 - 2030 (USD Million)
  • Table 3 Global Generative AI in Healthcare market by End-use, 2017 - 2030 (USD Million)
  • Table 3 Global Generative AI in Healthcare market by Application, 2017 - 2030 (USD Million)
  • Table 4 Global Generative AI in Healthcare market by Region, 2017 - 2030 (USD Million)
  • Table 5 North America Generative AI in Healthcare market by country, 2017 - 2030 (USD Million)
  • Table 6 Europe Generative AI in Healthcare market by country, 2017 - 2030 (USD Million)
  • Table 7 Asia Pacific Generative AI in Healthcare market by country, 2017 - 2030 (USD Million)
  • Table 8 Latin America Generative AI in Healthcare market by country, 2017 - 2030 (USD Million)
  • Table 9 MEA Generative AI in Healthcare market by country, 2017 - 2030 (USD Million)
  • Table 10 Key companies launching new products/services
  • Table 11 Key companies engaged in mergers & acquisition
  • Table 12 Key companies engaged in Research & development
  • Table 13 Key Companies engaged in expansion

List of Figures

  • Fig. 1 Generative AI in Healthcare Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Parent market analysis
  • Fig. 9 Market formulation & validation
  • Fig. 10 Generative AI in Healthcare market snapshot
  • Fig. 11 Generative AI in Healthcare market segment snapshot
  • Fig. 12 Generative AI in Healthcare market competitive landscape snapshot
  • Fig. 13 Market research process
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Generative AI in Healthcare Market, Component outlook key takeaways (USD Million)
  • Fig. 17 Generative AI in Healthcare Market: Component movement analysis (USD Million), 2022 & 2030
  • Fig. 18 Solutions market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 19 Services market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 20 Generative AI in Healthcare Market: Function outlook key takeaways (USD Million)
  • Fig. 21 Generative AI in Healthcare Market: Function movement analysis (USD Million), 2022 & 2030
  • Fig. 22 Virtual Nursing Assistants market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 23 Robot-Assisted AI Surgery market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 24 Administrative Process Optimization market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 25 Medical Imaging Analysis market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 26 Generative AI in Healthcare Market: End-use outlook key takeaways (USD Million)
  • Fig. 27 Generative AI in Healthcare Market: End-use movement analysis (USD Million), 2022 & 2030
  • Fig. 28 Clinical Research market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 29 Medical Centers market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 30 Diagnostic Centers market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 31 Others market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 32 Generative AI in Healthcare Market: Application outlook key takeaways (USD Million)
  • Fig. 33 Generative AI in Healthcare Market: Application movement analysis (USD Million), 2022 & 2030
  • Fig. 34 Clinical market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 35 System market revenue estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 Generative AI in Healthcare Market: Regional outlook, 2022 & 2030, USD Million
  • Fig. 38 North America Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 39 U.S. Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 40 Canada Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 41 Europe Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 42 UK Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 43 Germany Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 44 France Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 45 Asia Pacific Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 46 China Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 47 Japan Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 48 India Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 49 South Korea Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 50 Australia Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 51 Latin America Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 52 Brazil Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 53 Mexico Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 54 MEA Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 55 KSA Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 56 UAE Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 57 South Africa Generative AI in Healthcare market estimates and forecasts, 2017 - 2030 (USD Million)
  • Fig. 58 Strategy framework
  • Fig. 59 Company Categorization
目次
Product Code: GVR-4-68040-135-7

Generative AI In Healthcare Market Growth & Trends:

The global generative AI in healthcare market size is expected to reach USD 14.77 billion by 2030, according to a new report by Grand View Research, Inc.. The market is anticipated to grow at a compound annual growth rate (CAGR) of 36.7% from 2023 to 2030. Generative models in healthcare are advancing diagnostic accuracy by generating high-resolution medical images. These AI-powered models excel at producing intricate imaging, aiding in the detection and diagnosis of critical diseases like cancer, lesions, and abnormalities. The enhanced image quality enables healthcare professionals to identify subtle anomalies more effectively. Moreover, the efficiency and speed of generative models expedite the diagnostic process, enabling prompt intervention and improved patient outcomes.

Generative AI is utilized in drug discovery to create new drug compounds or optimize the existing ones, accelerating the drug development timeline. Additionally, it assists in predicting drug properties and potential side effects, offering valuable insights for informed decision-making in the pharmaceutical industry. For instance, DeepChem, an open-source platform created by Stanford University researchers, employs generative models and machine learning to drive advancements in computational chemistry for drug discovery. DeepChem offers a range of tools and models to optimize and analyze molecular compounds, catering to diverse applications in healthcare and pharmaceutical industries.

Generative AI is a transformative force in healthcare, enabling a profound shift towards personalized medicine. By leveraging an individual's genetic data and health history, generative AI algorithms can craft tailor-made treatment plans and medications. This innovative approach ensures that medical interventions are precisely aligned with a person's unique genetic makeup and health circumstances, maximizing treatment efficacy and minimizing adverse effects. The potential of generative AI to customize healthcare interventions marks a pivotal advancement in medicine, promising a future where treatments are optimized and personalized for everyone, ultimately improving overall healthcare outcomes.

Generative AI's foothold in the healthcare market of North America has strengthened significantly, showcasing a notable surge in growth. Advances in artificial intelligence and machine learning, particularly generative models, have propelled their applications within healthcare. From generating medical images for accurate diagnostics to aiding drug discovery processes, and personalizing treatment plans based on individual genetic profiles, the potential of generative AI is being actively explored and adopted. Collaborations between research institutions, healthcare organizations, and technology firms, along with substantial venture capital funding and supportive regulatory frameworks, further fuel the integration of generative AI into various healthcare domains. The demand for personalized medicine and a drive towards innovation are key factors contributing to the remarkable growth of generative AI in the healthcare sector throughout North America.

Generative AI In Healthcare Market Report Highlights:

  • Based on function, the medical imaging analysis segment dominated with a revenue share of 28.9% in 2022. Generative models, such as Generative Adversarial Networks (GANs) and Variational Autoencoders (VAEs), have shown significant promise in generating high-fidelity medical images
  • Based on end-use, the clinical research segment dominated the market with a revenue share of 29.3% in 2022. Generative AI has demonstrated substantial potential in assisting and expediting various aspects of clinical research like drug discovery, optimization of clinical trial designs, predictive analytics, and optimizing research processes
  • The pharmaceutical industry continued to embrace generative AI for drug discovery and development. AI-driven generative models accelerated the process of identifying potential drug candidates and optimizing existing ones, reducing the time and cost associated with bringing new medications to market
  • Generative AI is revolutionizing healthcare training with realistic virtual simulations. It helps create lifelike patient avatars and interactive surgical scenarios, enhancing the skills of healthcare professionals in a risk-free environment

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
    • 1.2.1. Information Procurement
  • 1.3. Information or Data Analysis
  • 1.4. Methodology
  • 1.5. Research Scope and Assumptions
  • 1.6. Market Formulation & Validation
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Generative AI in Healthcare Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Industry Challenge
  • 3.3. Generative AI in Healthcare Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Economic Landscape
      • 3.3.2.3. Social Landscape
      • 3.3.2.4. Technology Landscape
      • 3.3.2.5. Environmental Landscape
      • 3.3.2.6. Legal Landscape
  • 3.4. Use Cases Analysis

Chapter 4. Generative AI in Healthcare Market: Component Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Generative AI in Healthcare Market: Component Movement Analysis, USD Million, 2022 & 2030
  • 4.3. Solutions
    • 4.3.1. Solutions Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)

Chapter 5. Generative AI in Healthcare Market: Function Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Generative AI in Healthcare Market: Function Movement Analysis, USD Million, 2022 & 2030
  • 5.3. Virtual Nursing Assistants
    • 5.3.1. Virtual Nursing Assistants Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.4. Robot-Assisted AI Surgery
    • 5.4.1. Robot-Assisted AI Surgery Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.5. Administrative Process Optimization
    • 5.5.1. Administrative Process Optimization Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 5.6. Medical Imaging Analysis
    • 5.6.1. Medical Imaging Analysis Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)

Chapter 6. Generative AI in Healthcare Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Generative AI in Healthcare Market: End-use Movement Analysis, USD Million, 2022 & 2030
  • 6.3. Clinical Research
    • 6.3.1. Clinical Research Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 6.4. Medical Centers
    • 6.4.1. Medical Centers Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 6.5. Diagnostic Centers
    • 6.5.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)

Chapter 7. Generative AI in Healthcare Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Generative AI in Healthcare Market: Application Movement Analysis, USD Million, 2022 & 2030
  • 7.3. Clinical
    • 7.3.1. Clinical Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 7.4. System
    • 7.4.1. System Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)

Chapter 8. Generative AI in Healthcare Market: Regional Estimates & Trend Analysis

  • 8.1. Generative AI in Healthcare Market Share, By Region, 2022 & 2030, USD Million
  • 8.2. North America
    • 8.2.1. North America Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 8.3.2. U.K.
      • 8.3.2.1. U.K. Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 8.4.2. China
      • 8.4.2.1. China Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Japan Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Australia Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Mexico Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
      • 8.6.1.1. (USD MILLION)
    • 8.6.2. KSA
      • 8.6.2.1. KSA Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 8.6.3. UAE
      • 8.6.3.1. UAE Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 8.6.4. South Africa
      • 8.6.4.1. South Africa Generative AI in Healthcare Market Estimates and Forecasts, 2017 - 2030

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Company Market Positioning
  • 9.3. Participant's Overview
  • 9.4. Financial Performance
  • 9.5. Product Benchmarking
  • 9.6. Company Heat Map Analysis
  • 9.7. Strategy Mapping
  • 9.8. Company Profiles/Listing
    • 9.8.1. Google LLC
    • 9.8.2. IBM Watson
    • 9.8.3. Johnson & Johnson
    • 9.8.4. Microsoft Corporation
    • 9.8.5. Neuralink Corporation
    • 9.8.6. NioyaTech
    • 9.8.7. OpenAI
    • 9.8.8. Oracle
    • 9.8.9. Saxon
    • 9.8.10. Syntegra
    • 9.8.11. Tencent Holdings Ltd